Chelsea Therapeutics International is a pharmaceutical company that focuses on developing and commercializing therapeutics for various human diseases. Their main goal is to acquire, develop, and market products for the treatment of conditions such as neurogenic orthostatic hypotension, autoimmune disorders, and cancer. They are currently working on the development of droxidopa for symptomatic NOH ...